Navigation Links
Fighting parasitic infection inadvertently unleashes dormant virus
Date:6/26/2014

Signals from the immune system that help repel a common parasite inadvertently can cause a dormant viral infection to become active again, a new study shows.

Further research is necessary to understand the clinical significance of the finding, but researchers at Washington University School of Medicine in St. Louis said the study helps illustrate how complex interactions between infectious agents and the immune system have the potential to affect illness.

The results appear online June 26 in Science Express.

The scientists identified specific signals in mice that mobilize the immune system to fight tapeworms, roundworms and other helminths, parasites that infect nearly a quarter of all humans. The same signals cause an inactive herpes virus infection in the mice to begin replicating again.

The researchers speculated that the virus might be taking advantage of the host response to the worm infection, multiplying and spreading when the immune system's attention is fixed on fighting the worms.

"The fact that the virus can 'sense' the immune reaction to a worm and respond by reactivating is a remarkable example of co-evolution," said senior author Herbert W. Virgin IV, MD, PhD. "We think other interactions between multiple infectious agents and the immune system will be discovered over time that we will view as similarly sophisticated or maybe even devious. Understanding these interactions will help us survive in a complex microbial world."

Viral infections typically begin with a battle with the host's immune system. That clash may eliminate many copies of the virus, but some can survive and hide in the nucleus of long-lived host cells without replicating, entering a phase known as latency.

Scientists have observed several examples of latent viral infections, such as tuberculosis, becoming active again after parasitic infections, such as malaria. The new study is the first to show that this reactivation can be triggered by immune system signals, and is also the first to identify genetic elements in the virus that direct its reactivation from latency.

The researchers gave mice a virus similar to human Karposi's sarcoma-associated herpes virus, a virus that causes cancers common in AIDS patients. After the infection became latent, the researchers infected the mice with parasitic helminth worms. The parasite then caused the mouse immune system to make cytokines, signaling molecules that help summon the immune cells and other factors needed to attack the parasites.

But the same cytokines also caused the herpes virus to start reproducing.

"Viruses become latent because they can detect immune system signals that tell them not to replicate," said first author Tiffany Reese, PhD, the Damon Runyon Postdoctoral Fellow in Virgin's lab. "Now, for the first time, we've shown a virus can detect immune system signals that tell the virus to start replicating. The signals are a response to the parasite infection, but the virus has developed a way of 'eavesdropping' on that response."

Virgin, the Edward Mallinckrodt Professor and Head of Pathology and Immunology, emphasized that the finding only applies to a particular class of herpes viruses that does not include herpes simplex, a common cause of sexually transmitted disease, or cytomegalovirus, which causes problems in patients with compromised immune systems.

"The human health consequences of reactivating this type of virus are unclear," he said. "We need to learn much more about how common these types of interactions are between multiple types of pathogens and the immune system before we can consider the implications for clinical treatment. And now we've identified an important place to begin asking those kinds of questions."


'/>"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert  

Related biology news :

1. Potential cholesterol lowering drug has breast cancer fighting capabilities
2. Fighting cancer with dietary changes
3. Parents of overweight kids more likely to give schools failing grades for fighting obesity
4. Scientists figure out staying power of HIV-fighting enzyme
5. Virus-fighting genes linked to mutations in cancer
6. Fighting cancer with lasers and nanoballoons that pop
7. Fighting antibiotic resistance with molecular drill bits
8. Success of new bug-fighting approach may vary from field to field
9. Caltech-developed method for delivering HIV-fighting antibodies proven even more promising
10. Fighting flies
11. New strategy emerges for fighting drug-resistant malaria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fighting parasitic infection inadvertently unleashes dormant virus
(Date:7/2/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... company, presented its phase 1a findings of Neihulizumab, a biologic for the treatment ... in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... today announced that it has entered into a multi-year contract with Merus ... support their translational and clinical research strategy to discover and develop ground-breaking ...
(Date:6/23/2020)... ... June 23, 2020 , ... First Aid ... Ltd, a UK supplier and manufacturer of innovative portable renewable energy equipment, have ... the fight against the COVID-19 pandemic in Zambia. , One of Renovagen’s FAST ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using ... suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. ... has been using the zebrafish model to investigate the causes of leukaemia and ...
(Date:7/7/2020)... ... , ... Bio-IT World has announced the winners of the ... of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were honored. ... examples of how technology innovations and strategic initiatives can be powerful forces for ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... the launch of a new clinical diagnostics immuno-oncology service, TissueInsight . ... (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
Breaking Biology Technology: